Cargando…

Common and distinct neural effects of risperidone and olanzapine during procedural learning in schizophrenia: a randomised longitudinal fMRI study

RATIONALE: Most cognitive domains show only minimal improvement following typical or atypical antipsychotic treatments in schizophrenia, and some may even worsen. One domain that may worsen is procedural learning, an implicit memory function relying mainly on the integrity of the fronto-striatal sys...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumari, Veena, Ettinger, Ulrich, Lee, Seoung Eun, Deuschl, Christine, Anilkumar, Anantha P., Schmechtig, Anne, Corr, Philip J., ffytche, Dominic H., Williams, Steven C. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534487/
https://www.ncbi.nlm.nih.gov/pubmed/25980483
http://dx.doi.org/10.1007/s00213-015-3959-1
_version_ 1782385463874551808
author Kumari, Veena
Ettinger, Ulrich
Lee, Seoung Eun
Deuschl, Christine
Anilkumar, Anantha P.
Schmechtig, Anne
Corr, Philip J.
ffytche, Dominic H.
Williams, Steven C. R.
author_facet Kumari, Veena
Ettinger, Ulrich
Lee, Seoung Eun
Deuschl, Christine
Anilkumar, Anantha P.
Schmechtig, Anne
Corr, Philip J.
ffytche, Dominic H.
Williams, Steven C. R.
author_sort Kumari, Veena
collection PubMed
description RATIONALE: Most cognitive domains show only minimal improvement following typical or atypical antipsychotic treatments in schizophrenia, and some may even worsen. One domain that may worsen is procedural learning, an implicit memory function relying mainly on the integrity of the fronto-striatal system. OBJECTIVES: We investigated whether switching to atypical antipsychotics would improve procedural learning and task-related neural activation in patients on typical antipsychotics. Furthermore, we explored the differential effects of the atypical antipsychotics risperidone and olanzapine. METHODS: Thirty schizophrenia patients underwent functional magnetic resonance imaging during a 5-min procedural (sequence) learning task on two occasions: at baseline and 7–8 weeks later. Of 30 patients, 10 remained on typical antipsychotics, and 20 were switched randomly in equal numbers to receive either olanzapine (10–20 mg) or risperidone (4–8 mg) for 7–8 weeks. RESULTS: At baseline, patients (all on typical antipsychotics) showed no procedural learning. At follow-up, patients who remained on typical antipsychotics continued to show a lack of procedural learning, whereas those switched to atypical antipsychotics displayed significant procedural learning (p = 0.001) and increased activation in the superior-middle frontal gyrus, anterior cingulate and striatum (cluster-corrected p < 0.05). These neural effects were present as a linear increase over five successive 30-s blocks of sequenced trials. A switch to either risperidone or olanzapine resulted in comparable performance but with both overlapping and distinct task-related activations. CONCLUSIONS: Atypical antipsychotics restore procedural learning deficits and associated neural activity in schizophrenia. Furthermore, different atypical antipsychotics produce idiosyncratic task-related neural activations, and this specificity may contribute to their differential long-term clinical profiles.
format Online
Article
Text
id pubmed-4534487
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-45344872015-08-20 Common and distinct neural effects of risperidone and olanzapine during procedural learning in schizophrenia: a randomised longitudinal fMRI study Kumari, Veena Ettinger, Ulrich Lee, Seoung Eun Deuschl, Christine Anilkumar, Anantha P. Schmechtig, Anne Corr, Philip J. ffytche, Dominic H. Williams, Steven C. R. Psychopharmacology (Berl) Original Investigation RATIONALE: Most cognitive domains show only minimal improvement following typical or atypical antipsychotic treatments in schizophrenia, and some may even worsen. One domain that may worsen is procedural learning, an implicit memory function relying mainly on the integrity of the fronto-striatal system. OBJECTIVES: We investigated whether switching to atypical antipsychotics would improve procedural learning and task-related neural activation in patients on typical antipsychotics. Furthermore, we explored the differential effects of the atypical antipsychotics risperidone and olanzapine. METHODS: Thirty schizophrenia patients underwent functional magnetic resonance imaging during a 5-min procedural (sequence) learning task on two occasions: at baseline and 7–8 weeks later. Of 30 patients, 10 remained on typical antipsychotics, and 20 were switched randomly in equal numbers to receive either olanzapine (10–20 mg) or risperidone (4–8 mg) for 7–8 weeks. RESULTS: At baseline, patients (all on typical antipsychotics) showed no procedural learning. At follow-up, patients who remained on typical antipsychotics continued to show a lack of procedural learning, whereas those switched to atypical antipsychotics displayed significant procedural learning (p = 0.001) and increased activation in the superior-middle frontal gyrus, anterior cingulate and striatum (cluster-corrected p < 0.05). These neural effects were present as a linear increase over five successive 30-s blocks of sequenced trials. A switch to either risperidone or olanzapine resulted in comparable performance but with both overlapping and distinct task-related activations. CONCLUSIONS: Atypical antipsychotics restore procedural learning deficits and associated neural activity in schizophrenia. Furthermore, different atypical antipsychotics produce idiosyncratic task-related neural activations, and this specificity may contribute to their differential long-term clinical profiles. Springer Berlin Heidelberg 2015-05-19 2015 /pmc/articles/PMC4534487/ /pubmed/25980483 http://dx.doi.org/10.1007/s00213-015-3959-1 Text en © The Author(s) 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Investigation
Kumari, Veena
Ettinger, Ulrich
Lee, Seoung Eun
Deuschl, Christine
Anilkumar, Anantha P.
Schmechtig, Anne
Corr, Philip J.
ffytche, Dominic H.
Williams, Steven C. R.
Common and distinct neural effects of risperidone and olanzapine during procedural learning in schizophrenia: a randomised longitudinal fMRI study
title Common and distinct neural effects of risperidone and olanzapine during procedural learning in schizophrenia: a randomised longitudinal fMRI study
title_full Common and distinct neural effects of risperidone and olanzapine during procedural learning in schizophrenia: a randomised longitudinal fMRI study
title_fullStr Common and distinct neural effects of risperidone and olanzapine during procedural learning in schizophrenia: a randomised longitudinal fMRI study
title_full_unstemmed Common and distinct neural effects of risperidone and olanzapine during procedural learning in schizophrenia: a randomised longitudinal fMRI study
title_short Common and distinct neural effects of risperidone and olanzapine during procedural learning in schizophrenia: a randomised longitudinal fMRI study
title_sort common and distinct neural effects of risperidone and olanzapine during procedural learning in schizophrenia: a randomised longitudinal fmri study
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534487/
https://www.ncbi.nlm.nih.gov/pubmed/25980483
http://dx.doi.org/10.1007/s00213-015-3959-1
work_keys_str_mv AT kumariveena commonanddistinctneuraleffectsofrisperidoneandolanzapineduringprocedurallearninginschizophreniaarandomisedlongitudinalfmristudy
AT ettingerulrich commonanddistinctneuraleffectsofrisperidoneandolanzapineduringprocedurallearninginschizophreniaarandomisedlongitudinalfmristudy
AT leeseoungeun commonanddistinctneuraleffectsofrisperidoneandolanzapineduringprocedurallearninginschizophreniaarandomisedlongitudinalfmristudy
AT deuschlchristine commonanddistinctneuraleffectsofrisperidoneandolanzapineduringprocedurallearninginschizophreniaarandomisedlongitudinalfmristudy
AT anilkumarananthap commonanddistinctneuraleffectsofrisperidoneandolanzapineduringprocedurallearninginschizophreniaarandomisedlongitudinalfmristudy
AT schmechtiganne commonanddistinctneuraleffectsofrisperidoneandolanzapineduringprocedurallearninginschizophreniaarandomisedlongitudinalfmristudy
AT corrphilipj commonanddistinctneuraleffectsofrisperidoneandolanzapineduringprocedurallearninginschizophreniaarandomisedlongitudinalfmristudy
AT ffytchedominich commonanddistinctneuraleffectsofrisperidoneandolanzapineduringprocedurallearninginschizophreniaarandomisedlongitudinalfmristudy
AT williamsstevencr commonanddistinctneuraleffectsofrisperidoneandolanzapineduringprocedurallearninginschizophreniaarandomisedlongitudinalfmristudy